Adicet Bio (ACET)
(Delayed Data from NSDQ)
$0.67 USD
-0.02 (-2.19%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.66 -0.01 (-1.58%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Adicet Bio, Inc. has a market cap of $56.71M, which represents its share price of $0.69 multiplied by its outstanding shares number of 82.71M. As a small-cap company, ACET's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ACET 0.67 -0.02(-2.19%)
Will ACET be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACET based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACET
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know
ACET: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ACET
Adicet Bio (ACET) Advances Phase 1 Trial for Autoimmune Treatment | ACET Stock News
Adicet Bio doses first patient in second cohort of ADI-001 trial
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical ...
Adicet Bio (ACET) Receives Buy Rating from HC Wainwright & Co. | ACET Stock News
ACET Stock Potential Boosted by New Analyst Coverage | ACET Stock News